ONCorg Speaker Series: Virtual Grand Rounds & Oncology Webinars

Engage with global thought leaders, explore practice-changing biomarker data, review multidisciplinary tumor board cases, and earn CME credits from anywhere in the world.

View Upcoming Sessions Apply to Speak

Next-Generation Sequencing & ctDNA Liquid Biopsy: Clinical Consensus 2026

Keynote Faculty: Dr. Elena Rostova, MD, PhD (Director of Molecular Oncology & Genomics)

Precision Oncology 1.5 AMA PRA Category 1 Credits

Date: Wednesday, September 16, 2026 Time: 01:00 PM - 02:30 PM EST Platform: Virtual Live Stream (Zoom / ONCorg Studio) Tuition: Complimentary (Open Access)

Expert multidisciplinary panel discussing the integration of circulating tumor DNA assays into standard oncologic practice, tracking minimal residual disease (MRD), and early resistance detection.

Antibody-Drug Conjugates in HER2-Low Breast Cancer: Clinical Mastery

Keynote Faculty: Dr. Sramila Aithal, MD (Senior Medical Oncologist & Breast Cancer Specialist)

Breast Cancer 1.5 AMA PRA Category 1 Credits

Date: Sunday, September 27, 2026 Time: 11:00 AM - 12:30 PM EST Platform: Virtual Live Stream (ONCorg Global Portal) Tuition: Complimentary (Open Access)

Comprehensive review of recent Phase III data, payload delivery mechanisms, bystander antitumor killing, and monitoring for interstitial lung disease in advanced breast carcinoma.

Managing Severe Immune-Related Toxicities (irAEs) in Checkpoint Blockade

Keynote Faculty: Dr. Alan Goldstein, MD (Chief of Immuno-Oncology & Cellular Therapy)

Immunotherapy 2.0 AMA PRA Category 1 Credits

Date: Monday, October 05, 2026 Time: 02:00 PM - 03:30 PM EST Platform: Virtual Live Stream & Interactive Q&A Tuition: Complimentary (Open Access)

In-depth clinical algorithms for diagnosing and aggressively managing immune-mediated colitis, pneumonitis, myocarditis, and hypophysitis in patients receiving combination PD-1 and CTLA-4 inhibitors.

Targeting KRAS G12C and Overcoming Secondary Bypass Mutations

Keynote Faculty: Dr. David Chen, MD (Chief of Gastrointestinal Oncology)

Targeted Therapy 1.5 AMA PRA Category 1 Credits

Date: Saturday, October 17, 2026 Time: 12:00 PM - 01:30 PM EST Platform: Virtual Grand Rounds Webinar Tuition: Complimentary (Open Access)

Exploring the revolution in KRAS direct covalent inhibitors, combination EGFR blockade strategies, and novel multi-RAS inhibitors entering early-phase human trials.

Interested in Presenting at an Upcoming ONCorg Webinar?

We invite clinical oncologists, academic researchers, and biotech leaders to present original trial data and clinical insights.

Submit Guest Speaker Proposal